Acelrx Pharma

ACRX NASDAQ
2.740
-0.060
-2.14%
Closed 16:00 05/24 EDT
Open
2.810
Prev Close
2.800
High
2.860
Low
2.705
Volume
899.74K
Avg Vol (3M)
2.08M
52 Week High
5.05
52 Week Low
1.990
% Turnover
1.14%
Market Cap
216.22M
1D
5D
1M
3M
1Y
5Y

Comments

No Data

Related

Webull offers Acelrx Pharma ACRX stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

AcelRx Pharmaceuticals, Inc. is a pharmaceutical company focused on the development and commercialization of therapies for the treatment of moderate-to-severe acute pain. The Company operates through the segment, which includes development and commercialization of product candidates for the treatment of pain. Its lead product candidates include ARX-04, Zalviso, which utilize sublingual sufentanil, delivered through a non-invasive route of administration, and ARX-03. ARX-04 is meant for the treatment of moderate-to-severe acute pain to be administered by a healthcare professional to a patient in medically supervised settings. Zalviso is meant for the management of moderate-to-severe acute pain in hospitalized adult patients. ARX-03 provides mild sedation, anxiety reduction and pain relief for patients undergoing painful procedures in a physician's office. It also includes ARX-02, which is meant for the treatment of patients who suffer from breakthrough pain (BTP) due to cancer.
MORE >

Recently

Name
Price
%Change